mitoxantrone
Showing 1 - 25 of 79
Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Gilteritinib 40 MG Oral Tablet
- +4 more
-
Lexington, KentuckyUniversity of Kentucky
Oct 27, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Clofarabine
- Mitoxantrone
-
Valhalla, New York
- +1 more
Oct 29, 2021
Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)
Not yet recruiting
- Lymphoblastic Leukemia
- Dexamethasone
- +8 more
-
Palo Alto, CaliforniaStanford University
Apr 27, 2023
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Cladribine
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 18, 2022
Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)
Completed
- Acute,Leukemia, Lymphoid
- Dasatinib
- +12 more
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Aug 2, 2022
Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level
Not yet recruiting
- Relapsed Adult AML
- Refractory AML
- Navitoclax Dose Level -1
- +10 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023
Non-Hodgkins Lymphoma Trial in Fort Myers, Nashville (Cyclophosphamide, Mitoxantrone, Vincristine)
Neuromyelitis Optica, Myelitis, Transverse, Demyelinating Autoimmune Diseases, CNS Trial in Buffalo (Mitoxantrone)
Completed
- Neuromyelitis Optica
- +3 more
- Mitoxantrone
-
Buffalo, New YorkBaird Multiple Sclerosis Center
Dec 23, 2020
Acute Myeloid Leukemia Trial in Worldwide (Alvocidib, Cytarabine, Mitoxantrone)
Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in
Recruiting
- Recurrent Adult Acute Myeloid Leukemia
- +2 more
- Sirolimus
- +3 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 7, 2020
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,
Completed
- Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood B-Lymphoblastic Lymphoma
- dexamethasone
- +18 more
-
San Diego, California
- +2 more
Sep 13, 2022
Myeloid Malignancies Trial in Australia, United Kingdom, United States (Magrolimab, Azacitidine, Venetoclax)
Recruiting
- Myeloid Malignancies
- Magrolimab
- +6 more
-
Birmingham, Alabama
- +12 more
Apr 6, 2022
Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)
Terminated
- Follicular Lymphoma
- Bendamustine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 1, 2020
Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)
Recruiting
- Leukemia, Monocytic, Acute
- Pediatric AML
- Cladribine
- +5 more
-
Foshan, Guangdong, China
- +8 more
Mar 28, 2022
Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate, Idarubicin, Cytarabine)
Completed
- Acute Myeloid Leukemia
- Crenolanib besylate
- +7 more
-
Houston, TexasMD Anderson Cancer Center
Jul 17, 2020
Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- ITMHA
- +13 more
-
Los Angeles, California
- +17 more
Jun 6, 2022
Acute Myelogenous Leukemia Trial in Boston (Brentuximab Vedotin, Mitoxantrone, Etoposide)
Completed
- Acute Myelogenous Leukemia
- Brentuximab Vedotin
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Apr 12, 2020
Leukemia Trial in Hershey (Clofarabine, Mitoxantrone, Etoposide)
Terminated
- Leukemia
- Clofarabine
- +2 more
-
Hershey, PennsylvaniaPenn State Hershey Cancer Institute
Jul 22, 2019
Medium Dose of Cytarabine and Mitoxantrone
Unknown status
- Acute Myelogenous Leukemia
- Chemotherapy
- Flow Cytometer
- +2 more
-
Shenzhen, Guangdong, ChinaShenzhen
Jul 16, 2019
Acute Myeloid Leukaemia Trial in Worldwide (Gemtuzumab ozogamicin, Liposomal daunorubicin, Mitoxantrone)
Recruiting
- Acute Myeloid Leukaemia
- Gemtuzumab ozogamicin
- +6 more
-
Adelaide, Australia
- +67 more
Sep 30, 2021
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Kansas City (Velcade, Methotrexate, Methotrexate / Hydrocortisone
Terminated
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Velcade
- +6 more
-
Kansas City, MissouriChildren's Mercy Hospital
Jul 23, 2019
Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia Trial in
Terminated
- Acute Lymphoblastic Leukemia
- +2 more
- Decitabine
- +6 more
-
Los Angeles, California
- +27 more
Oct 5, 2020